Skip to main content
Daniel Chao, MD, Ophthalmology, La Jolla, CA

DanielLeeChaoMDPhD

Ophthalmology La Jolla, CA

Retinal Disease

Assistant Professor of Ophthalmology

Dr. Chao is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Chao's full profile

Already have an account?

  • Office

    9415 Campus Point Dr
    La Jolla, CA 92093
    Phone+1 858-434-6290

Summary

  • I am a retina surgeon and clinician-scientist focused on translational research and innovation in retinal disease.

Education & Training

  • University of California (San Francisco)
    University of California (San Francisco)Fellowship, Surgical Retina and Vitreous, 2014 - 2016
  • University of Miami/Jackson Health System/Bascom Palmer Eye Institute
    University of Miami/Jackson Health System/Bascom Palmer Eye InstituteResidency, Ophthalmology, 2011 - 2014
  • Santa Clara Valley Medical Center
    Santa Clara Valley Medical CenterInternship, Transitional Year, 2010 - 2011
  • Stanford University School of Medicine
    Stanford University School of MedicineClass of 2010

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2014 - 2026
  • NJ State Medical License
    NJ State Medical License 2021 - 2025
  • American Board of Ophthalmology Ophthalmology

Awards, Honors, & Recognition

  • Allergan FIRST Program Participant Allergan
  • Emerging Vision Scientist AEVR, 2016
  • William F. Hoyt Teaching Award UCSF Ophthalmology, 2016
  • Join now to see all

Publications & Presentations

PubMed

Press Mentions

  • Pain Control After Intravitreal Injection Using Topical Nepafenac 0.3% or Pressure Patching: A Randomized, Placebo-Controlled Trial
    Pain Control After Intravitreal Injection Using Topical Nepafenac 0.3% or Pressure Patching: A Randomized, Placebo-Controlled TrialApril 29th, 2020
  • Current Practice Preferences and Safety Protocols for Intravitreal Injection of Anti-Vascular Endothelial Growth Factor Agents
    Current Practice Preferences and Safety Protocols for Intravitreal Injection of Anti-Vascular Endothelial Growth Factor AgentsMarch 22nd, 2020
  • Researchers Identify Gene with Functional Role in Aging of Eye
    Researchers Identify Gene with Functional Role in Aging of EyeJanuary 15th, 2020
  • Join now to see all

Grant Support

  • ASCRS Foundation Research GrantASCRS2013–2014

Professional Memberships

Other Languages

  • Chinese (Mandarin), Spanish